Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer

Theranostics, a combination of therapy and diagnostics, is a field of personalized medicine involving the use of the same or similar radiopharmaceutical agents for the diagnosis and treatment of patients. Prostate-specific membrane antigen (PSMA) is a promising theranostic target for the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Plichta, Kristin A., Graves, Stephen A., Buatti, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621856/
https://www.ncbi.nlm.nih.gov/pubmed/34829977
http://dx.doi.org/10.3390/ijms222212095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621856/
https://www.ncbi.nlm.nih.gov/pubmed/34829977
http://dx.doi.org/10.3390/ijms222212095

Ejemplares similares